Duality Biotherapeutics
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Preliminary Data from Two Clinical Trials with ADC Candidates were Presented Orally at the 2025 ASCO Annual Meeting 2025-06-05 10:46
Duality Bio Appoints Hua Mu as Global Chief Medical Officer 2025-04-07 12:52
Avenzo Therapeutics and DualityBio Announce Exclusive Global License for Potential Best-In-Class EGFR/HER3 Antibody-Drug Conjugate 2025-01-07 22:00
Duality announced the appointment of Dr. Pasi A. Jänne as Member of SAB 2022-12-15 21:00
Duality announced the appointment of Dr. Yver as Chairman of SAB 2022-10-03 22:00
1